Index tracked: MSCI ACWI with Developed Markets 100% hedged to USD Index
TER
0.21%+ trans. 0.00%
Fund size
—
Tracking difference
−0.07%3-year avg
🇮🇹 tax rate
—white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 11 Aug 2015 · costs from the KID as of 26 Aug 2026 · 1 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
L'obiettivo del Fondo è l'apprezzamento del capitale. Il Fondo replica la performance giornaliera di un indice azionario, denominato SCI ACWI Net Total Return Index (l'"Indice"), al netto delle commissioni e dei costi, di conseguenza è gestito passivamente.
Il Fondo investe in strumenti finanziari derivati ("SFD") con UBS AG, Succursale di Londra ("UBS") quale controparte. Il Fondo può inoltre investire in titoli (ad esempio azioni societarie e obbligazioni emesse da società e governi). In base ai termini degli SFD, la performance dell'Indice viene…
Performance since series start (in euro) — base 100
11 Aug 2015 → 3 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 334 (17 Aug 2026) · low 84 (9 Feb 2016) · last 333. Past performance is not indicative of future results.
The live sheet, always up to date rebalix.com/en/etf/IE00BYM11J43 Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.